Crohn’s and colitis are much more manageable when we share our experiences with each other. Education events, chapter meetings, and fundraising activities are great opportunities to meet people who are living with IBD, their families and friends, and to learn of local resources and health professionals to support you and your family.

Senior Director, Community Engagement
Josephine Cavarra
416-920-5035 ext. 244

Leadership Giving Officer, Western Canada
Susan Hampton
604-314-1151

Development Coordinator
Teri McGeachie
250-213-7761
1-800-513-8202

West Jet Plane

The British Columbia Fly Away Raffle

We are pleased to announce the British Columbia WestJet Fly Away Raffle in support of Crohn's and Colitis Canada. This is your chance to win a Westjet Gift of Flight Voucher and this year we are ...

 • 
Online (You must be a resident of BC)
 • 
Talk About Guts Live

Talk About Guts LIVE: Volunteer Voices – Learn about the Remarkable Volunteers Supporting our Work

Following National Volunteer Week 2023, Crohn’s and Colitis Canada will be hosting a special event to honour the impactful work our volunteers do, nationwide. Lori Radke (President and CEO ...

 • 
Online through Zoom
 • 
Remember to bookmark this page.

British Columbia & Yukon Office

PO Box 47147 City Square
Vancouver, BC V5Z 4L6

bc@crohnsandcolitis.ca 1-800-513-8202

Search by Postal Code

News

The Canadian Inflammatory Bowel Disease Research Consortium awards first $1M Pioneer Grant from Takeda Canada

The Canadian Inflammatory Bowel Disease Research Consortium awards first $1M Pioneer Grant from Takeda Canada

Crohn’s and Colitis Canada and Pfizer Canada Announce 2022 Women in IBD Award Recipients

Crohn’s and Colitis Canada and Pfizer Canada Announce 2022 Women in IBD Award Recipients

Health Canada has approved SKYRIZI® (risankizumab) an intravenous and subcutaneous medication treatment for adults with moderately to severely active Crohn's Disease

Health Canada has approved SKYRIZI® (risankizumab) an intravenous and subcutaneous medication treatment for adults with moderately to severely active Crohn's Disease

 1 2 3 4 5 6 7 8 9 10